Real-world evidence shows clinically meaningful weight loss in people receiving Saxenda®
People treated with Saxenda® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in…
People treated with Saxenda® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in…
Shield Therapeutics PLC on Wednesday reported significantly widened loss for 2017, as it progresses on Feraccru product study and commercialisation.…